BME 155: Biotechnology and Drug Development
Recommended for students interested in careers in the biopharmaceutical industry. Focuses on recombinant DNA technology and the drug-development process, including discovery research; preclinical testing; clinical trials; and regulatory review, as well as manufacturing and production considerations. Students may not receive credit for this course and course 255. (Also offered as Biology: Molecular Cell & Dev 179. Students cannot receive credit for both courses.) Prerequisite(s): Biology 20A and Biology 100 or Biochemistry and Molecular Biology 100A. Enrollment limited to 15. P. Berman
5 Credits
While the information on this web site is usually the most up to date, in the event of a discrepancy, please contact your adviser to confirm which information is correct.